Adam Feuerstein is a regular writer for TheStreet.com. TheStreet.com is a publisher and has registered as an investment adviser with the U.S. Securities and Exchange Commission. The author is restricted from owning individual securities other than stock or options in TheStreet.com.

TheStreet.com Biotech Select contains the author's own opinions, and none of the information contained therein constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. You further understand that Mr. Feuerstein will not advise you personally concerning the nature, potential, value or suitability of any particular security, portfolio of securities, transaction, investment strategy or other matter. To the extent any of the information contained in TheStreet.com Biotech Select may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

Investing in the stocks chosen for TheStreet.com Biotech Select recommended list is risky and speculative. The companies may have limited operating histories and little available public information, and the stocks they issue may be volatile and illiquid. Trading in such securities can result in immediate and substantial losses of the capital invested. You should use only risk capital, and not capital required for other purposes, such as retirement savings, student loans, mortgages or education.

TheStreet.com Biotech Select contains a recommended list of stocks chosen by the author in accordance with his stated investment strategy. Your actual results may differ from results reported for the recommended list for many reasons, including, without limitation: (i) performance results for the recommended list do not reflect actual trading commissions that you may incur; (ii) performance results for the recommended list do not account for the impact, if any, of certain market factors, such as lack of liquidity, that may affect your results; (iii) the stocks chosen for the recommended list may be volatile, and although the "purchase" or "sale" of a security in the recommended list will not be effected in the recommended list until confirmation that the email alert has been sent to all subscribers, delivery delays and other factors may cause the price you obtain to differ substantially from the price at the time the alert was sent; and (iv) the prices of stocks in the recommended list at the point in time you begin subscribing to TheStreet.com Biotech Select may be higher than such prices at the time such stocks were chosen for inclusion in the recommended list.

Past results are not necessarily indicative of future performance.